This inventor holds 1 USPTO granted patent. Top assignee: Altergon Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eleonora Dellera: Innovator in Pharmaceutical Compositions
Introduction
Eleonora Dellera is a notable inventor based in Lugano, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. Her work focuses on improving the stability and administration of medications, which is crucial for patient care.
Latest Patents
Dellera holds a patent for a solid orodispersible pharmaceutical composition in film form containing lorazepam. This invention is characterized by its high stability throughout the shelf life of the product. The compositions are designed for oral administration and are suitable for patients who may be unconscious or have difficulty swallowing, such as dysphagic patients. This advancement represents a significant step forward in making medications more accessible and easier to administer.
Career Highlights
Throughout her career, Eleonora has demonstrated a commitment to innovation in the pharmaceutical industry. Her work at Altergon SA has allowed her to focus on developing solutions that enhance patient outcomes. With her expertise, she has contributed to the advancement of pharmaceutical formulations that prioritize patient safety and efficacy.
Collaborations
Dellera has collaborated with esteemed colleagues, including Andrea Maria Giori and Roberta Lollini. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.
Conclusion
Eleonora Dellera's contributions to pharmaceutical compositions highlight her dedication to improving patient care through innovative solutions. Her patent for a solid orodispersible composition demonstrates her ability to address critical challenges in medication administration. As she continues her work at Altergon SA, her impact on the pharmaceutical industry is sure to grow.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
